Literature DB >> 7830114

Primary lung cancer SPECT imaging with pentavalent technetium-99m-DMSA.

T Hirano1, H Otake, I Yoshida, K Endo.   

Abstract

UNLABELLED: To assess the clinical role of 99mTc(V)-DMSA in primary lung cancers, SPECT imaging was performed on 31 patients with suspected lung cancer.
METHODS: Planar and SPECT images were obtained at 3 to 4 hr after intravenous injection of approximately 555 MBq 99mTc(V)-DMSA. Two uptake ratios (the maximum counts/pixel in the lesion to the average counts in normal tissue) were calculated.
RESULTS: Various types of primary lung cancers (adenocarcinoma, squamous-cell carcinoma, small-cell carcinoma, large-cell carcinoma and bronchial carcinoid tumor) were imaged by 99mTc(V)-DMSA SPECT. Approximately 90% of the lung carcinomas showed increased uptake and were clearly demonstrated by SPECT images. Four cases incidentally revealed osseous metastatic lesion. Three benign lesions did not show increased uptake. Three cases were false-negative and there were no false-positive cases for the primary lesions.
CONCLUSION: Technetium-99m(V)-DMSA SPECT images demonstrated approximately 90% of the primary lung cancers. Uptake ratios were higher in squamous-cell carcinomas than adenocarcinomas. Evaluation of mediastinal tumor extension and nodal metastatic lesion was very difficult by high blood-pool activity in the major cardiovascular structures due to slow blood-pool clearance. However, 99mTc(V)-DMSA SPECT imaging was very useful for detecting primary lung cancers and metastatic lesions to the osseous structures.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7830114

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  8 in total

1.  In vitro and in vivo studies with pentavalent technetium-99m dimercaptosuccinic acid.

Authors:  A S Lam; M R Puncher; P J Blower
Journal:  Eur J Nucl Med       Date:  1996-12

2.  Correlation between 99mTc-(V)-DMSA uptake and constitutive level of phosphorylated focal adhesion kinase in an in vitro model of cancer cell lines.

Authors:  Delphine Denoyer; Nathalie Perek; Nathalie Le Jeune; Jérôme Cornillon; Francis Dubois
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-03-23       Impact factor: 9.236

3.  Technetium-99m tetrofosmin uptake in lung cancer: comparison with thallium-201.

Authors:  I Matsunari; S Kinuya; T Nishikawa; M Matoba; K Murakita; M Ohguchi; K Ichiyanagi; J Taki; N Tonami; K Hisada
Journal:  Ann Nucl Med       Date:  1996-02       Impact factor: 2.668

4.  Skeletal affinity of Tc(V)-DMS is bone cell mediated and pH dependent.

Authors:  Kazuko Horiuchi-Suzuki; Aya Konno; Mayumi Ueda; Yoko Fukuda; Saori Nishio; Kazuyuki Hashimoto; Hideo Saji
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-11-29       Impact factor: 9.236

5.  Relationship of cell proliferation (Ki-67) to 99mTc-(V)DMSA uptake in breast cancer.

Authors:  Vassilios J Papantoniou; Michael A Souvatzoglou; Varvara J Valotassiou; Androniki N Louvrou; Constantina Ambela; John Koutsikos; Dimitrios Lazaris; Julie K Christodoulidou; Maria G Sotiropoulou; Maria J Melissinou; Aris Perperoglou; Spyridon Tsiouris; Cherry J Zerva
Journal:  Breast Cancer Res       Date:  2003-12-11       Impact factor: 6.466

6.  Role of 99mTc-(V)DMSA in detecting tumor cell proliferation.

Authors:  Fatma Al-Saeedi
Journal:  Anal Chem Insights       Date:  2007-12-13

Review 7.  Dimercaptosuccinic acid: A multifunctional cost effective agent for imaging and therapy.

Authors:  Jaya Shukla; Bhagwant Rai Mittal
Journal:  Indian J Nucl Med       Date:  2015 Oct-Dec

8.  Assessment of tracer 99mTc(V)-DMSA uptake as a measure of tumor cell proliferation in vitro.

Authors:  Fatma J Al-Saeedi; Princy M Mathew; Yunus A Luqmani
Journal:  PLoS One       Date:  2013-01-15       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.